News

The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis.

The Centers for Disease Control and Prevention has collated in one location training materials for health care professionals during the COVID-19 emergency, including webinars, videos and online courses.

The FEMA Healthcare Resilience Task Force has released a COVID-19 Hospital Resource Package, which offers tools to help hospitals prepare for and respond to the pandemic.

The Food and Drug Administration announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.

The Department of Health and Human Services will partner with more than a dozen biopharmaceutical companies and the European Medicines Agency to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes to respond to the pandemic, the National Institutes of Health announced.

The Centers for Medicare & Medicaid Services has created two new Healthcare Common Procedure Coding System codes (U0003 and U0004) to bill under Medicare Part B for clinical diagnostic laboratory tests that use high-throughput technologies to detect and diagnose the novel coronavirus.

The Centers for Medicare & Medicaid Services issued guidance implementing legislative provisions specific to enhanced federal funding for Medicaid and Children’s Health Insurance Program.

President Trump announced guidelines that states and localities can use for easing social distancing restrictions, including criteria for employers, individuals and hospitals.

As the COVID-19 surge wanes in different parts of the country, the AHA, American College of Surgeons, American Society of Anesthesiologists, and Association of periOperative Registered Nurses today released a roadmap for safely resuming elective surgery.

This week, the women and men of America’s hospitals and health systems are continuing their heroic efforts caring for tens of thousands of COVID-19 patients.

President Trump directed the Secretary of Defense to authorize 100% federal cost-sharing for the governors of Iowa, Kansas, Maine, Nebraska, Oklahoma and Vermont to deploy the National Guard to support their respective COVID-19 emergency assistance efforts for up to 31 days.

The Department of Health and Human Services awarded $90 million for Ryan White HIV/AIDS Program recipients as part of the Coronavirus Aid, Relief and Economic Security Act.

The Department of Health and Human Services reached an agreement with General Electric to produce 50,000 ventilators by July 13.

The Food and Drug Administration issued a pair of emergency use authorizations for serology tests to detect for the presence of coronavirus antibodies.

During the COVID-19 emergency, the Food and Drug Administration will not take action in certain circumstances against a registered outsourcing facility for compounding certain drugs to treat hospitalized patients with COVID-19; using a bulk drug substance not on the 503B bulk list; or not meeting current good manufacturing process requirements.

The Centers for Medicare & Medicaid Services released new guidance implementing several provisions included in the Coronavirus Aid, Relief, and Economic Security Act.

The AHA, American Medical Association, and American Nurses Association urged the Department of Health and Human Services to identify and address disparities in the federal response to COVID-19.

Health care providers who receive funds from the $100 billion Public Health and Social Services Emergency Fund must within 30 days of receipt attest to receiving the funds and agree to the terms and conditions of payment.

The AHA urged the Department of Health and Human Services to release “substantial additional emergency funds to all hospitals in an expedited manner” as part of the second wave of funding from the Coronavirus Aid, Relief, and Economic Security Act.

The Centers for Disease Control and Prevention recently reported a tripling of hepatitis C cases over the past decade, with the highest rate of infections occurring in younger adults between 20-39 years old.